MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 107 filers reported holding MENLO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,253,000 | +83.5% | 1,302,503 | +184.2% | 0.00% | – |
| Q1 2020 | $1,228,000 | +75.7% | 458,267 | +204.2% | 0.00% | – |
| Q4 2019 | $699,000 | -1.5% | 150,645 | -4.9% | 0.00% | – |
| Q3 2019 | $710,000 | +9.6% | 158,451 | +46.4% | 0.00% | – |
| Q2 2019 | $648,000 | -17.5% | 108,209 | +8.3% | 0.00% | – |
| Q1 2019 | $785,000 | +93.3% | 99,911 | +1.6% | 0.00% | – |
| Q4 2018 | $406,000 | -58.1% | 98,379 | -0.1% | 0.00% | – |
| Q3 2018 | $970,000 | +77.0% | 98,490 | +45.9% | 0.00% | – |
| Q2 2018 | $548,000 | -78.8% | 67,485 | -1.8% | 0.00% | -100.0% |
| Q1 2018 | $2,583,000 | – | 68,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 1,461,552 | $11,473,000 | 9.29% |
| Vivo Capital, LLC | 4,011,236 | $31,488,000 | 3.14% |
| DAFNA Capital Management LLC | 600,030 | $4,710,000 | 2.03% |
| GREAT POINT PARTNERS LLC | 2,057,027 | $16,148,000 | 1.60% |
| MANGROVE PARTNERS IM, LLC | 561,138 | $4,405,000 | 0.59% |
| Alambic Investment Management, L.P. | 66,996 | $526,000 | 0.22% |
| FIRST MANHATTAN CO. LLC. | 2,256,903 | $17,716,000 | 0.10% |
| Orbimed Advisors | 633,920 | $4,976,000 | 0.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 198,451 | $1,558,000 | 0.06% |
| Baker Brothers Advisors | 700,000 | $5,495,000 | 0.04% |